MedicinePOM

Repaglinide

A tablet taken before meals to lower blood sugar in type 2 diabetes.

Clinical information

Common uses

type 2 diabetes, alongside diet and exercise

Common side effects

low blood sugar (hypoglycaemia)
upper respiratory infection
headache
diarrhoea and feeling sick
joint and back pain

Cautions

skip the dose if you skip a meal
not for type 1 diabetes or ketoacidosis
not used with NPH insulin — heart risk

Interactions

gemfibrozil — must not be combined
clopidogrel — avoid; dose limited if unavoidable
cyclosporine — dose limited
ketoconazole, clarithromycin, trimethoprim — may raise repaglinide levels
rifampin, barbiturates, carbamazepine — may reduce its effect
beta blockers — may hide low blood sugar warning signs

Pregnancy: no drug-linked risk identified — only if prescribed

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, repaglinide label, setid 6ae28683-28cc-408e-90f9-6a3dddfc668d (accessed 2026-08-16)

Approved brands & formulations3

Brand name	Dosage form	Strength	Importer	Category
Repaglinide	Tablet	1 mg	—	POM
Repaglinide	Tablet	0.5 mg	—	POM
Repaglinide	Tablet	2 mg	—	POM